FDA approves first topical skin growth treatment; Teva to cut 14,000 jobs; Novartis Oncology CEO resigns
The new VP of market access at Mitsubishi Tanabe Pharma America talks about driving access and bringing to market the first FDA-approved ALS drug in years.
The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.
Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."
GCI Health has confirmed new hire Kath Kerry and maternity leave returner Rikki Jones as co-MDs of its London operation, the network's second hub alongside its New York headquarters.
Cannes Lions' longtime leader, chief spokesman, and a figure many viewed as the heart and soul of the global creativity festival will be moving on after the 2018 event ends.
DeVine will oversee the agency's health IT and medical device work.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.
The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson's trial
W2O's Windy City office has added three health and analytics leaders over the past six months.
GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick
Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.
Midway through Campaign's audience with Publicis Groupe's Maurice Lévy, a heavily French-accented voice exclaims, "Now it is time for the real boss to arrive."
The blogger talks the challenges of influencer marketing in healthcare, chronic disease, and big brand activations.
The divisional VP and head of public affairs has seen it all, including the transformation from a traditional comms organization to a more dynamic and content-led group.
MM&M and PRWeek have revealed the 2017 Health Influencer 50, a list honoring professionals across the health spectrum for their passion, determination, and innovative thinking that has helped guide the industry through two turbulent and exciting decades.
Optum vet Miller replaces Jessica Boden.
Trade group PhRMA's CEO talks about his first year in the job amid public outrage about price gouging.
From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.
The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.
Every agency in the biz claims to have a "unique" culture and one that fuels a great deal of its success.
The successes of these pharma execs show that there's no one path to professional bliss.
Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.
Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.
Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.
Incisive Health will next month welcome Francesca Scassellati Sforzolini as head of its Brussels office.